Articles

Click the image above to read Dr Bowling’s recent article

Dr. Bowling is an accomplished author.  His work appears in a wide variety of lay and professional publications.  Below you will find a partial listing of some of the articles and abstracts that Dr. Allen Bowling has written on the subject of Multiple Sclerosis care and treatment as well as lifestyle and unconventional medicine.

 

Professional Articles for Foundations (partial listing):

  1. Bowling AC. Diet and Nutrtition in MS. IOMSNews, Winter 2017, 4-9, 15.
  2. Bowling AC. Vitamin D and MS: Implications for clinical practice. Clinical Bulletin, Professional Resource Center, National MS Society, 2017.
  3. Bowling AC. Complementary and alternative medicine in MS. Clinical Bulletin, Professional Resource Center, National MS Society, 2017.
  4. Bowling AC. Integrative neurology: patient- and disease-centered approaches. AlterMed Research Foundation Newsletter, Spring 2010, 2-5.

 

Lay Brochures and Monographs (partial listing):

  1. Bowling AC, Stewart TM. Vitamins, Minerals, and Herbs in MS. Patient Booklet, National MS Society, 2015.
  2. Bowling AC, Neld C. Complementary and Alternative Medicines. Patient Booklet, MS Essential Series, National MS Society of the United Kingdom, 2012.
  3. Bowling AC, Stewart TM. Acupuncture and MS. Patient Brochure, National MS Society, 2009.
  4. Bowling AC, Stewart TM. Thinking About Complementary and Alternative Medicine. Patient Monograph, MS Association of America, 2006.

 

Lay Articles (partial listing)

  1. Bowling AC. “The Big Mistake Most MS Patients Make,” Bottom Line Health, March 2018, pp. 9-11.
  2. Bowling AC. “Conventional Or Alternative? Exploring ‘Borderzone’ Therapies,” Momentum, Winter 2011-2012, pp. 32-34.
  3. Bowling AC. “Some Cures That Weren’t,” Momentum, Fall 2011, pp. 39-41.
  4. Bowling AC. “Vitamin D: Dandy? Dastardly? Or Debatable?” Momentum, Summer 2011, pp. 39-42.
  5. Bowling AC. “Placebos and nocebos—techniques to optimize MS management?” Momentum, Spring 2011, pp. 45-47.
  6. Bowling AC. Healthy you—vitamin D and NMO. The Spectrum (publication of the Guthy-Jackson Charitable Foundation), 2;2010:7.
  7. Bowling AC. “Marijuana and MS—an unfinished story,” Momentum, Fall 2010, pp. 33-35.
  8. Bowling AC. Complementary and alternative medicine: a globally important topic in MS. [Invited guest editor for issue on alternative medicine.] MS in Focus (publication of MS International Federation), 15;2010:4-6.
  9. Bowling AC. “Learning from traditional Chinese medicine and Ayurveda,” Momentum, Summer 2010, pp. 48-50.
  10. Bowling AC. “Wise choices in action: The example of acai,” Momentum, Spring 2010, pp. 46-47.
  11. Bowling AC. “Making wise choices,” Momentum, Winter 2009-2010, pp. 34-36.
  12. Bowling AC. “Music and the brain may be a therapeutic duet,” Momentum, Fall 2009, pp. 43-45.
  13. Bowling AC. “Unconventional therapies for stress and anxiety,” Momentum, Summer 2009, pp. 48-50.
  14. Bowling AC. “The 411 on low dose naltrexone,” Momentum, Spring 2009, pp. 44-46.
  15. Bowling AC. “Herbs and MS, Part 3: All that is green is not always good,” Momentum, Winter 2008-2009, pp. 39-40.
  16. Bowling AC. “Herbs and MS, Part 2: Common herbs and common MS symptoms,” Momentum, Summer 2008, pp. 37-39. [reproduced in: Intouch, Autumn 2009, pp. 8-10 (quarterly publication of MS Australia)]
  17. Bowling AC. Voodoo death, placebos, and optimal health. MS Focus, Summer 2008, pp. 43-45. [national publication of the MS Foundation]
  18. Bowling AC. “Herbs and MS, Part 1: About herbs—and MS,” Momentum, Spring 2008, pp. 40-41.
  19. Bowling AC. “Pinning your hope on…acupuncture,” InsideMS, April-May 2007, pp. 54-56.
  20. Bowling AC. “The omega-3 factor,” InsideMS, Dec 2006-Jan 2007, pp. 52-55.
  21. Bowling AC. “Mind over yoga,” InsideMS, Aug-Sept 2006, pp. 54-55.
  22. Bowling AC. “CAM and bladder issues,” InsideMS, April-May 2006, pp. 52-53.
  23. Bowling AC, Stewart TM. A reasonable approach to diet. Open Door Newsletter. Feb 2006, pp. 8-9. [national publication of MS Trust (MS organization in United Kingdom)]

 

Journal Articles:

  1. Jenkins DJA, Wolever TMS, Taylor RH, Barker HM, Fielden H, Baldwin JM, Newman HC, Bowling AC, Goff DV. Bioavailability to man of carbohydrate in foods. Proc. Nutrition Soc. 1980; 39:11.
  2. Jenkins DJA, Wolever TMS, Tayler RH, Barker H, Fielden H, Baldwin JM, Bowling AC, Newman HC, Jenkins AL, Goff DV. Glycemic index of foods: a physiological basis for carbohydrate exchange. Am. J. Clin. Nutrition 1981; 34:362-366.
  3. Jenkins DJA, Ghafari H, Wolever TMS, Tayler, RH, Jenkins AL, Barker HM, Fielden H, Bowling AC. Relationship between rate of digestion of foods and post-prandial glycaemia. Diabetologia 1982; 22:450-455.
  4. Bowling AC, DeLorenzo RJ. Micromolar affinity benzodiazepine receptors: identification and characterization in central nervous system. Science 1982; 216:1247-1250.
  5. DeLorenzo RJ, Gonzales B, Goldenring J, Bowling AC, Jacobson R. Ca2+-calmodulin tubulin kinase system and its role in mediating the Ca2+ signal in brain. Prog. Brain Res. 1982; 56:255-286.
  6. DeLorenzo RJ, Bowling AC, Taft WC. A molecular approach to the development of anticonvulsants. Ann. NY Acad. Sci. 1986; 477:238-246.
  7. Bowling AC, DeLorenzo RJ. Photoaffinity labeling of a novel benzodiazepine binding protein in rat brain. Eur. J. Pharmacol. 1988; 135:97-100.
  8. Bowling AC, Mutisya EM, Walker LC, Price DL, Cork LC, Beal MF. Age-dependent impairment of mitochondrial function in primate brain. J. Neurochem. 1993; 60:1964-1967.
  9. Bowling AC, Schulz JB, Brown RH, Beal MF. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J. Neurochem., 1993; 61:2322-2325.
  10. Bowling AC, Beal MF. Aging, energy, and Alzheimer’s disease. In: Masters C, Bayreuther K, Trillet M, Christen Y, eds. Amyloid Protein Precursor in Development, Aging, and Alzheimer’s Disease. Springer-Verlag, 1994, 216-227.
  11. Rosen DR, Bowling AC, Patterson D, Usdin TB, Sapp P, Mezey E, McKenna-Yasek D, O’Regan J, Rahmani Z, Ferrante RJ, Brownstein MJ, Kowall NW, Beal MF, Horvitz HR, Brown RH. A frequent superoxide dismutase-1 codon 4 missense mutation is associated with familial amyotrophic lateral sclerosis and decreased enzyme activity. Hum. Molec. Gen., 1994; 3:981-987.
  12. Esteban J, Rosen DR, Bowling AC, Sapp P, McKenna-Yasek D, O’Regan JP, Beal MF, Horvitz HR, Brown RH. Identification of two novel mutations and a new polymorphism in the gene for Cu, Zn superoxide dismutase in patients with familial amyotrophic lateral sclerosis. Hum. Molec. Gen., 1994; 3:997-998.
  13. Mutisya EM, Bowling AC, Beal MF. Cortical cytochrome oxidase activity is reduced in Alzheimer’s disease. J. Neurochem., 1994; 63:2179-2184.
  14. Bowling AC, Beal MF. Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci., 1995; 56:1151-1171.
  15. Bowling AC, Barkowski EE, McKenna-Yasek D, Horvitz HR, Beal MF, Brown RH. Superoxide dismutase concentration and activity in familial amyotrophic lateral sclerosis. J. Neurochem., 1995; 64:2366-2369.
  16. Browne SE, Bowling AC, MacGarvey U, Baik MJ, Berger SC, Muqit MMK, Bird ED, Beal MF. Oxidative damage and metabolic dysfunction in Huntington’s disease: selective vulnerability of the basal ganglia. Ann. Neurol., 1997; 41:646-653.
  17. Ferrante RJ, Browne SE, Shinobu LA, Bowling AC, Baik MJ, MacGarvey U, Kowall NW, Brown RH, Beal MF. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J. Neurochem., 1997; 69:2064-2074.
  18. Browne SE, Bowling AC, Baik MJ, Gurney M, Brown RH, Beal MF. Metabolic dysfunction in familial, but not sporadic, amyotrophic lateral sclerosis. J. Neurochem., 1998; 71:281-287.
  19. Bowling AC, Ibrahim R, Stewart TM. Alternative medicine and multiple sclerosis: an objective review from an American perspective. Int. J. MS Care, 2000; 2:14-21.
  20. Bowling AC, Stewart TM. Current complementary and alternative therapies of multiple sclerosis. Curr. Treatment Options Neurol., 2003; 5:55-68.
  21. Bowling AC. Worthless weed or pot of gold? [Invited editorial on marijuana and MS] Int. J. MS Care, 2003; 5:138, 166.
  22. Bowling AC. Complementary and alternative medicine in multiple sclerosis: dispelling common myths about CAM. Int. J. MS Care, 2005; 7:42-44.
  23. Stewart TM, Bowling AC. Polyunsaturated fatty acid supplementation in MS. Int. MS J., 2005; 12:88-93.
  24. Bowling AC. Cannabinoids in MS—are we any closer to knowing how best to use them? Mult. Scler., 2006; 12:523-525.
  25. Stewart TM, Tran ZV, Bowling AC. Factors related to fatigue in multiple sclerosis. Int. J. MS Care, 2007;9:29-34.
  26. Kennedy P, Bowling A, Saunders C, Beach B, Denney D, Conner J. Adherence to glatiramer acetate therapy among individuals with multiple sclerosis who participated in a voluntary support program alone or in partnership with their multiple sclerosis center. IOMSN Research Resource, 2010,1-8.
  27. Bowling AC. Complementary and alternative medicine in multiple sclerosis. Continuum Lifelong Learning Neurol., 2010;16:78-89.
  28. Bowling AC. Complementary and alternative medicine in multiple sclerosis. Continuum Lifelong Learning Neurol., 2010;16:78-89.
  29. Bowling AC. Complementary and alternative medicine and multiple sclerosis. Neurol Clin North America, 2011;29:465-480.
  30. Yadav V, Bever C, Bowen J, Bowling A, et al. Summary of evidence-based guideline: Complementary and alternative medicine in multiple sclerosis: Report of the guideline development subcommittee of the American Academy of Neurology. Neurol, 2014;82:1083-1092.
  31. Bowling AC. Integrating Vitamin D into the Overall Therapeutic Strategy for MS. Int J MS Care, 2015;17Suppl2:17-21
  32. Kappos L, Bar-Or A, Cree BAC, et al. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomized, phase 3 study. Lancet, 2018;391:1263-1273.
  33. Bowling AC. Integrative care for patients with multiple sclerosis: What is integrative care, and why should clinicians care about it? Prac Neurol, 2018;July/Aug2018:74-79.

Abstracts:

  1. Bowling AC, DeLorenzo RJ. Micromolar affinity benzodiazepine receptors in brain membrane. Am. Soc. Neurochem., 1982.
  2. Bowling AC, DeLorenzo RJ. Anticonvulsant receptors in brain membrane. Am. Acad. Neurol.,1982.
  3. Bowling AC, DeLorenzo RJ. Multiple phenytoin binding sites: Identification and characterization in brain membrane. Soc. Neurosci., 1982.
  4. Bowling AC, DeLorenzo RJ. Identification of a novel benzodiazepine binding protein in rat brain. Soc. Neurosci., 1986.
  5. Bowling AC, DeLorenzo RJ. A novel benzodiazepine binding protein in rat brain. Am. Acad. Neurol., 1988.
  6. Taft WC, Bowling AC, DeLorenzo RJ. Reversible anticonvulsant displacement of benzodiazepine (BZ) photolabeling to 65 kDa BZ binding protein. Soc. Neurosci., 1988.
  7. Bowling AC, Mutisya EM, Beal MF. Aging-associated impairment of mitochondrial energy metabolism in rhesus monkeys. Am. Acad. Neurol., 1993.
  8. Bowling AC, Schulz JB, Brown RH, Beal MF. Superoxide dismutase activity and oxidative damage in brain tissue from patients with familial and sporadic amyotrophic lateral sclerosis. Soc. Neurosci., 1993.
  9. Mutisya EM, Bowling AC, Walker LC, Price DL, Cork LC, Vecsei L, Beal MF. Impaired energy metabolism in aging and Alzheimer’s disease. Soc. Neurosci., 1993.
  10. Bowling AC, Brown RH, Beal MF. Superoxide dismutase activity and markers of oxidative damage in sporadic and familial ALS. Am. Acad. Neurol., 1994.
  11. Bowling AC, Barkowski EE, Schulz JB, MacGarvey U, Brown RH, Beal MF. Oxidative markers, electron transport chain activity, and superoxide dismutase activity in familial and sporadic amyotrophic lateral sclerosis. Soc. Neurosci., 1994.
  12. Browne SE, Bowling AC, Beal MF. Mitochondrial enzyme activities in Huntington’s disease. Soc. Neurosci., 1994.
  13. Kowall NW, Schulz J, Ferrante R, Bowling AC, Beckman J, Brown RH, Beal MF. A superoxide dismutase-1 antisense oligodeoxynucleotide produces free radical mediated damage and neuronal degeneration in vivo. American Neurological Assoc., 1994.
  14. Browne SE, Bowling AC, MacGarvey U, Beal MF. Oxidative DNA damage and impaired mitochondrial metabolism in Huntington’s disease. Soc. Neurosci., 1995.
  15. Bowling A C. An objective review of herbal medicine and vitamin supplements relevant to multiple sclerosis. Consortium of Multiple Sclerosis Centers, 1999; Multiple Sclerosis, 1999; 5, suppl. 1: S134.
  16. Bowling AC, Stewart TM. A website focusing on complementary and alternative medicine for multiple sclerosis. Consortium of Multiple Sclerosis Centers, 2000.
  17. Bowling AC, Stewart TM. A web-based system for providing and collecting information about complementary and alternative medicine that is relevant to multiple sclerosis. Consortium of Multiple Sclerosis Centers, 2001.
  18. Bowling AC, Stewart TM. Efficacy, safety, and prevalence of acupuncture use among a group of people with MS: a web-based survey. Consortium of Multiple Sclerosis Centers, 2002; Int J MS Care, 2002; 4: 95.
  19. Stewart TM, Smeltzer SC, Bowling AC. A survey with individualized feedback regarding low bone mineral density among people with MS. Consortium of Multiple Sclerosis Centers, 2003; Int J MS Care, 2003;5:87.
  20. Stewart TM, Bowling AC. A survey of issues related to fatigue among a large group of people with MS. Consortium of Multiple Sclerosis Centers, 2003; Int J MS Care;5:96.
  21. Smeltzer S, Stewart TM, Bowling AC. Results of on-line survey about low bone mineral density among people with MS. American Public Health Association Annual Meeting, San Francisco, CA, 2003.
  22. Bowling A, Stewart T. A survey of issues related to marijuana use among a large group of people with multiple sclerosis. Consortium of Multiple Sclerosis Centers, 2004.
  23. Maloni H, O’Leary M, Kennedy P, Stewart T, Bowling A. Site reactions due to disease modifying therapy and associated alleviating behaviors. Consortium of Multiple Sclerosis Centers, 2004.
  24. Bowling A. Complementary and alternative medicine in MS [invited speaker], ECTRIMS, 2004; Mult Scler, 2004;10:S114.
  25. Fraser R, Kraft GH, Ehde D, Johnson K, Brown T, Severson B, Yorkston K, Klasner E, Dudgeon BJ, Bombardier C, Clemmons D, Bowling A, Rumrill P, McKee P, Whittenberg A, Manley M, Foley F, Holland N. Development and dissemination of coping skill modules in MS rehabilitation. Consortium of Multiple Sclerosis Centers, 2005.
  26. Bowling A, Stewart T. A survey of dietary supplement use among a large group of people with multiple sclerosis. Consortium of Multiple Sclerosis Centers, 2005.
  27. Dole K, Nagra R, Kennedy P, Tourtellotte W, Bowling A. Tissue bank collaboration: benefits to the research community. Consortium of Multiple Sclerosis Centers, 2005.
  28. Stewart T, Wilken J, Bowling A. Survey of issues related to cognitive dysfunction among a large group of people with multiple sclerosis. Consortium of MS Centers, 2006; Int J MS Care;8:71.
  29. Dole KC, Nagra RM, Nilsen E, Kleinschmidt-DeMasters BK, Kennedy PK, Bowling AC. Postmortem tissue is important component of multiple sclerosis (multiple sclerosis) research: critical role of MS tissue banks. Consortium of MS Centers, 2006; Int J MS Care;8:77-78.
  30. Dole KC, Nagra RM, Nilsen E, Kleinschmidt-DeMasters BK, Kennedy PK, Bowling AC. New directions in tissue banking. Consortium of MS Centers, 2007; Int J MS Care;9:56.
  31. Stewart T, Bowling AC, Hatgidakis J. A survey of issues related to prayer and spirituality among a large group of people with MS. Consortium of MS Centers, 2007; Int J MS Care;9:76.
  32. Kennedy P, Bowling A, Saunders C, Beach B, Conner J, Denney D. Partnership between Shared Solutions and MS office nurses: adherence enhancement program. Consortium of MS Centers, 2007; Int J MS Care;9:66.
  33. Dole K, Nagra RM, Lipton H, Valyi-Nagy T, Corti M, Kleinschmidt-Demasters B, Kennedy P, Bowling AC. Networking of tissue banks. Consortium of MS Centers, 2008, Int J MS Care;10,suppl1:42-43.
  34. Stewart TM, Kennedy P, Maloni H, O’Leary M, Tran ZV, Bowling AC, Buckley K. Survey of issues related to injection-site reactions caused by injectable FDA-approved multiple sclerosis medications. Consortium of MS Centers, 2008, Int J MS Care;10,suppl1:Int J MS Care;51.
  35. Bowling AC. Alternative medicine in multiple sclerosis. Pan-Asian Committee for Treatment and Research of MS, 2009, Mult Scler, 2010;16:261.